News

Filter News By

Clear Filters

  1. CF Foundation Awards Icagen Up to $11 Million for Nonsense Mutation Research

    May 1, 2018

    Icagen Inc. will focus on drug discovery, screening for compounds that could suppress nonsense mutations, and using computer modeling to identify molecules that are suitable to be developed into drugs.

  2. CF Foundation Awards Up to $25 Million for the Development of a Novel Drug to Reduce Inflammation in CF

    January 30, 2018

    The drug company Corbus Pharmaceuticals will start its next Phase 2 clinical trial to test a potential inflammation-targeting drug in people with cystic fibrosis in the first quarter of 2018.

  3. CFFT Activities Transferred to the CF Foundation

    December 12, 2017

    Over the course of 2018, we will be transferring the activities of Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) to the CF Foundation.

  4. CF Foundation Officially Opens One-of-a-Kind Research Lab

    September 16, 2016

    The lab will use the latest scientific advances –- including stem cell research and gene editing –- to accelerate new treatments for cystic fibrosis.

  5. CF Foundation Awards $23M to 11 Sites in its Research Development Program

    August 14, 2015

    The Cystic Fibrosis Foundation has awarded more than $23 million across 11 sites in its Research Development Program (RDP), a network of research centers that bring together top-notch scientists from different disciplines to apply their expertise to the challenges of treating cystic fibrosis.

  6. The Brightest Minds in Science, Medicine and Industry Meet to Discuss Advances and Challenges in CF Research

    June 12, 2015

    The CF Foundation recently hosted the CFF Research Conference: Pushing the Frontiers, bringing together nearly 150 basic scientists, clinical researchers, graduate students and pharmaceutical company representatives to share information on recent advances and critical challenges in CF drug discovery.

Follow Us On